← Back to Clinical Trials
Recruiting NCT07529548

NCT07529548 The New Beginnings Podcast: Brief Audio Intervention for Parents From Divorced and Separated Families

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07529548
Status Recruiting
Phase
Sponsor Charla Aubrey Rhodes
Condition Parent Child Relationship
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-08-15
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
New Beginnings Podcast ProgramNo Interventions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-08-15 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to learn if the New Beginnings Podcast can help children whose parents are going through a divorce or separation. The podcast shares parenting strategies that have been shown to help in past in-person and online programs. This study will also look at how easy it is for parents to use the podcast and how helpful they find it. The main questions it aims to answer are: 1. Do parents find the podcast easy to use, helpful, and relevant? 2. Does listening to the podcast improve children's mental health? 3. Does the podcast help parents build stronger relationships with their children and reduce conflict between parents? Researchers will compare families who use the podcast to families on a waitlist to see if the podcast makes a difference. Participants will: 1. Listen to podcast episodes over the course of the study 2. Answer questions about their experiences with the podcast 3. Complete surveys about their child's well-being, their parenting, and family relationships This study will include 80 parents and their children.

Eligibility Criteria

Inclusion Criteria: For Parents, eligibility criteria are: 1. divorced, separated, separated but never married, or divorcing/separating within the last two years; 2. one or more children between the ages of 8-18 years old; 3. have in-person contact with their child(ren) at least three hours per week or have at least one overnight visit every other week; 4. have access to a smartphone with internet that can play audio files; 5. English speaking. For children, eligibility criteria are: 1. have a parent who is participating in the trial; 2. be between the ages of 8-18 and 3. have access to a computer to complete assessments. If a parent has more than one child aged 8-18 interested in participating, we will randomly select one child to ensure independence of responses. Exclusion Criteria: \-

Contact & Investigator

Central Contact

Charla A Rhodes, Ph.D., Clinical Psychology

✉ carhode1@asu.edu

📞 ‪(602) 767-2426‬

Frequently Asked Questions

Who can join the NCT07529548 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, studying Parent Child Relationship. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07529548 currently recruiting?

Yes, NCT07529548 is actively recruiting participants. Contact the research team at carhode1@asu.edu for enrollment information.

Where is the NCT07529548 trial being conducted?

This trial is being conducted at Tempe, United States.

Who is sponsoring the NCT07529548 clinical trial?

NCT07529548 is sponsored by Charla Aubrey Rhodes. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology